Serum activin A levels are increased in patients with metastatic cancer [6] and with anorexia/cachexia syndrome [7], and ActRIIB antagonism reverses cachexia and muscle wasting in tumor-bearing mice [8], which is evidence that activin signaling supports systemic disease progression. The gene discussed is INHBE; the disease is neoplasm.